A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

AkzoNobel & Atul to start monochloroacetic acid production in India in 2019

Each partner to hold a 50-percent stake in the joint venture, to be registered as Anaven

BS B2B Bureau  |  Mumbai 

Dutch specialty company and Atul Ltd, a part of Lalbhai Group, have formally agreed the joint venture partnership announced last year for the production of (MCA) in India. The companies will establish a new plant at Atul's facility in Gujarat by first quarter 2019, with each partner holding a 50-percent stake in the joint venture, to be registered as Anaven.

As well as building on AkzoNobel's leading position in the MCA market - with plants in the Netherlands, China, Japan and the US - the partnership will also enhance Atul's status as a key global supplier of the 2,4-D, which uses MCA as a key raw material.

"The Anaven partnership will contribute to our vision of driving profitable growth for Specialty in India, which is an important growth market. Our partnership with Atul is part of an asset light strategy to expand our leading position in MCA through shared incremental investments," said Knut Schwalenberg, managing director of AkzoNobel's industrial business.

Sunil Lalbhai, chairman and managing director of Atul Ltd, added, “We are delighted to partner with to bring state-of-the-art technology for MCA to India from a world class company and develop a long-lasting relationship with to create value for all the Stakeholders. The Anaven project will be in sync with the 'Make in India' initiative of the Government of India."

The partnership will use chlorine and hydrogen manufactured by Atul to produce monochloroacetic acid, taking advantage of both Atul's existing infrastructure and the leading eco-friendly hydrogenation technology of From an initial annual capacity of 32,000 tonnes per annum (TPA) at start-up, the plant has been designed for future expansion to 60,000 TPA. The facility will produce enough MCA to meet Atul’s growing demand for MCA and supply the expanding Indian market.

is an essential building block in the chemical industry and is used in a wide variety of For example, customers use MCA to produce thickening agents for the food, oil, mining, personal care and detergent industries. It is also used in agrochemicals, adhesives, pharmaceuticals, thermo-stabilizers, surfactants and cosmetics.

AkzoNobel & Atul to start monochloroacetic acid production in India in 2019

Each partner to hold a 50-percent stake in the joint venture, to be registered as Anaven

Each partner to hold a 50-percent stake in the joint venture, to be registered as Anaven
Dutch specialty company and Atul Ltd, a part of Lalbhai Group, have formally agreed the joint venture partnership announced last year for the production of (MCA) in India. The companies will establish a new plant at Atul's facility in Gujarat by first quarter 2019, with each partner holding a 50-percent stake in the joint venture, to be registered as Anaven.

As well as building on AkzoNobel's leading position in the MCA market - with plants in the Netherlands, China, Japan and the US - the partnership will also enhance Atul's status as a key global supplier of the 2,4-D, which uses MCA as a key raw material.

"The Anaven partnership will contribute to our vision of driving profitable growth for Specialty in India, which is an important growth market. Our partnership with Atul is part of an asset light strategy to expand our leading position in MCA through shared incremental investments," said Knut Schwalenberg, managing director of AkzoNobel's industrial business.

Sunil Lalbhai, chairman and managing director of Atul Ltd, added, “We are delighted to partner with to bring state-of-the-art technology for MCA to India from a world class company and develop a long-lasting relationship with to create value for all the Stakeholders. The Anaven project will be in sync with the 'Make in India' initiative of the Government of India."

The partnership will use chlorine and hydrogen manufactured by Atul to produce monochloroacetic acid, taking advantage of both Atul's existing infrastructure and the leading eco-friendly hydrogenation technology of From an initial annual capacity of 32,000 tonnes per annum (TPA) at start-up, the plant has been designed for future expansion to 60,000 TPA. The facility will produce enough MCA to meet Atul’s growing demand for MCA and supply the expanding Indian market.

is an essential building block in the chemical industry and is used in a wide variety of For example, customers use MCA to produce thickening agents for the food, oil, mining, personal care and detergent industries. It is also used in agrochemicals, adhesives, pharmaceuticals, thermo-stabilizers, surfactants and cosmetics.

image
Business Standard
177 22